Lemonade Stock Turned 21% Sweeter Last Month. Here's How.

Shares of Lemonade (NYSE: LMND) rose 21.1% in March 2026, according to data from S&P Global Market Intelligence. The AI-powered insurance company bounced back from a brutal February sell-off, though the ride was anything but smooth. The path from $52 to $63 included a mid-month spike, a late-month stumble, and plenty of volatility in between. The stock is still down 12% for the year, but at least the bleeding has paused.

Why Lemonade spiked mid-month (and stumbled at the end)

The biggest single-day move came on March 17, when Lemonade shares jumped 15.8% on heavy volume. Analyst firm Morgan Stanley upgraded the stock to Buy and raised its price target from $80 to $85, citing Lemonade's new autonomous vehicle insurance product for self-driving Tesla (NASDAQ: TSLA) cars, and a partnership with an unnamed EV manufacturer.

When a major bank says nice things about your AI strategy, people listen.

CEO Daniel Schreiber didn't let analysts do all the talking, though. His March 4 blog post, "Why Incumbents Won't Catch Up," read like a manifesto for AI-native disruption. The piece compared Lemonade's efficiency metrics to legacy giants like Berkshire Hathaway's (NYSE: BRKA) (NYSE: BRKB) GEICO (which apparently runs on 600 systems that don't talk to each other).

Schreiber's post wasn't subtle. Effective? Maybe. The stock was up 9% by the time Morgan Stanley weighed in two weeks later, reversing February's deep dive.

The company also joined the NASDAQ Internet Index on March 25. That's not necessarily headline news, but index inclusion can boost trading volumes via passive fund flows.

Then the macro gremlins showed up. Rising oil prices, inflation concerns, and geopolitical uncertainty sent investors fleeing from growth stocks. Lemonade's March jump could have been substantially higher.

Image source: Getty Images.

Is Lemonade's rally sustainable?

Lemonade's stock chart in 2026 looks like a heart-rate monitor during a horror movie. Up 15% on February's earnings, down 20% the next week due to valuation concerns in an unpredictable economy, up 21% in March, and still underwater for the year. Lemonade is not a stock for the faint of heart.

But zoom out and the picture looks different. Revenue is growing at a rate north of 50%. Loss ratios are improving. Cash flow has turned positive in recent reports. The company keeps signing deals and expanding its insurance products, while its services are turning more effective and profitable thanks to heaps of real-world risk data.

Lemonade's stock is expensive, for sure. The company is still unprofitable and shares are trading at the highest price-to-sales ratio in the property and casualty insurance sector. And insurance regulators move at roughly the speed of continental drift, on a cold day. But Schreiber's core argument is hard to dismiss: Lemonade was built for AI from the ground up, while incumbents are trying to teach an old-school industry how to code.

That doesn't mean the stock goes up tomorrow or next month. But for investors who believe AI will reshape insurance, Lemonade's 12% year-to-date decline may look more like a buying opportunity than a warning sign. Personally, I doubled down on my Lemonade holdings two weeks ago, a few days after the Morgan Stanley bump. I expect great things from this disruptive innovator.

Anders Bylund has positions in Lemonade. The Motley Fool has positions in and recommends Berkshire Hathaway, Lemonade, and Tesla. The Motley Fool has a disclosure policy.